These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 31669736)
1. Deferiprone and efonidipine mitigated iron-overload induced neurotoxicity in wild-type and thalassemic mice. Sripetchwandee J; Khamseekaew J; Svasti S; Srichairatanakool S; Fucharoen S; Chattipakorn N; Chattipakorn SC Life Sci; 2019 Dec; 239():116878. PubMed ID: 31669736 [TBL] [Abstract][Full Text] [Related]
2. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130 [TBL] [Abstract][Full Text] [Related]
3. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice. Khamseekaew J; Kumfu S; Wongjaikam S; Kerdphoo S; Jaiwongkam T; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N Eur J Pharmacol; 2017 Mar; 799():118-127. PubMed ID: 28192097 [TBL] [Abstract][Full Text] [Related]
4. Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice. Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N Exp Physiol; 2016 Apr; 101(4):521-39. PubMed ID: 26824522 [TBL] [Abstract][Full Text] [Related]
5. Deferiprone has less benefits on gut microbiota and metabolites in high iron-diet induced iron overload thalassemic mice than in iron overload wild-type mice: A preclinical study. Sriwichaiin S; Thiennimitr P; Thonusin C; Sarichai P; Buddhasiri S; Kumfu S; Nawara W; Kittichotirat W; Fucharoen S; Chattipakorn N; Chattipakorn SC Life Sci; 2022 Oct; 307():120871. PubMed ID: 35952729 [TBL] [Abstract][Full Text] [Related]
6. Combined iron chelator and T-type calcium channel blocker exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice. Kumfu S; Khamseekaew J; Palee S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N Eur J Pharmacol; 2018 Mar; 822():43-50. PubMed ID: 29366843 [TBL] [Abstract][Full Text] [Related]
7. T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice. Kumfu S; Chattipakorn S; Chinda K; Fucharoen S; Chattipakorn N Eur J Haematol; 2012 Jun; 88(6):535-48. PubMed ID: 22404220 [TBL] [Abstract][Full Text] [Related]
8. Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels. Kumfu S; Chattipakorn S; Fucharoen S; Chattipakorn N Drug Chem Toxicol; 2013 Jul; 36(3):329-34. PubMed ID: 23050671 [TBL] [Abstract][Full Text] [Related]
9. Effects of iron overload condition on liver toxicity and hepcidin/ferroportin expression in thalassemic mice. Kumfu S; Chattipakorn SC; Fucharoen S; Chattipakorn N Life Sci; 2016 Apr; 150():15-23. PubMed ID: 26921633 [TBL] [Abstract][Full Text] [Related]
10. Combined iron chelator with N-acetylcysteine exerts the greatest effect on improving cardiac calcium homeostasis in iron-overloaded thalassemic mice. Sumneang N; Kumfu S; Khamseekaew J; Siri-Angkul N; Fucharoen S; Chattipakorn SC; Chattipakorn N Toxicology; 2019 Nov; 427():152289. PubMed ID: 31542421 [TBL] [Abstract][Full Text] [Related]
11. A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice. Kumfu S; Khamseekaew J; Palee S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N Free Radic Res; 2018 Jan; 52(1):70-79. PubMed ID: 29207893 [TBL] [Abstract][Full Text] [Related]
12. Mitochondrial calcium uniporter blocker prevents cardiac mitochondrial dysfunction induced by iron overload in thalassemic mice. Kumfu S; Chattipakorn S; Fucharoen S; Chattipakorn N Biometals; 2012 Dec; 25(6):1167-75. PubMed ID: 22910858 [TBL] [Abstract][Full Text] [Related]
13. MRI imaging and histopathological study of brain iron overload of β-thalassemic mice. Yatmark P; Huaijantug S; Teerapan W; Svasti S; Fucharoen S; Morales NP Magn Reson Imaging; 2019 Sep; 61():267-272. PubMed ID: 31128226 [TBL] [Abstract][Full Text] [Related]
14. A selective T-type Ca2+ channel blocker R(-) efonidipine. Shin MC; Kim CJ; Min BI; Ogawa S; Tanaka E; Akaike N Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483 [TBL] [Abstract][Full Text] [Related]
15. The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium. Tanaka H; Komikado C; Shimada H; Takeda K; Namekata I; Kawanishi T; Shigenobu K J Pharmacol Sci; 2004 Dec; 96(4):499-501. PubMed ID: 15599089 [TBL] [Abstract][Full Text] [Related]
16. A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload. Sripetchwandee J; Wongjaikam S; Krintratun W; Chattipakorn N; Chattipakorn SC Neuroscience; 2016 Sep; 332():191-202. PubMed ID: 27403880 [TBL] [Abstract][Full Text] [Related]
17. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure. Kinoshita H; Kuwahara K; Takano M; Arai Y; Kuwabara Y; Yasuno S; Nakagawa Y; Nakanishi M; Harada M; Fujiwara M; Murakami M; Ueshima K; Nakao K Circulation; 2009 Sep; 120(9):743-52. PubMed ID: 19687356 [TBL] [Abstract][Full Text] [Related]
18. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. Sasaki H; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohhira M; Oyama T; Miyashita Y; Shirai K J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells. Imagawa K; Okayama S; Takaoka M; Kawata H; Naya N; Nakajima T; Horii M; Uemura S; Saito Y J Cardiovasc Pharmacol; 2006 Jan; 47(1):133-8. PubMed ID: 16424797 [TBL] [Abstract][Full Text] [Related]
20. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels. Tanaka H; Shigenobu K Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]